Wessel Thomas 4
4 · Flex Pharma, Inc. · Filed Jan 19, 2018
Insider Transaction Report
Form 4
Wessel Thomas
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-17+100,000→ 100,000 totalExercise: $3.98Exp: 2028-01-17→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in 48 successive equal monthly installments measured from January 17, 2018.